SCHEMBL17089904

SCHEMBL17089904

O=C(O)CCOCCOCCOCCN(CCOCCC(=O)O)S(=O)(=O)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
PTPN1 P18031 2/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP8 P22894 1/20 0.44
MMP13 P45452 1/20 0.44
TBXA2R P21731 4/20 0.43
HTT P42858 2/20 0.43
THRB P10828 1/20 0.41
NPSR1 Q6W5P4 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALDH1A1 P00352 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
SLC10A6 Q3KNW5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17089909 1.00 KMT2A (0.46) KMT2AMEN1PTPN1CA1CA2
SCHEMBL17089905 0.98 CA1 (0.45) KMT2AMEN1PTPN1CA1CA2
SCHEMBL31618146 0.86 KMT2A (0.46) KMT2AMEN1PTPN1CA1CA2
SCHEMBL526711 0.83 MEN1 (0.49) KMT2AMEN1PTPN1CA1CA2
SCHEMBL17089907 0.82 NR1D1 (0.42) KMT2AMEN1PTPN1CA1CA2
SCHEMBL14973609 0.81 KMT2A (0.49) KMT2AMEN1PTPN1CA1CA2
SCHEMBL14973611 0.81 KMT2A (0.49) KMT2AMEN1PTPN1CA1CA2
SCHEMBL29719600 0.78 KMT2A (0.50) KMT2AMEN1PTPN1CA1CA2
SCHEMBL29238388 0.78 KMT2A (0.56) KMT2AMEN1PTPN1CA1CA2
SCHEMBL968214 0.77 VCAM1 (0.54) KMT2AMEN1PTPN1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9139615-B2 High-affinity, dimeric inhibitors of PSD-95 as efficient neuroprotectants against ischemic brain damage and for treatment of pain UNIVERSITY OF COPENHAGEN (DK) 2015-09-22 US disclosed